Tiziana Life Sciences Ltd
TLSA
$2.03
-$0.10-4.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.25M | 7.25M | 3.72M | 3.72M | 1.13M |
| Total Receivables | 4.95M | 4.95M | 3.64M | 3.64M | 6.27M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 517.00K | 517.00K | 92.00K | 92.00K | 355.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 53.00K | 53.00K | -- |
| Total Current Assets | 12.72M | 12.72M | 7.51M | 7.51M | 7.75M |
|
|
|||||
| Total Current Assets | 12.72M | 12.72M | 7.51M | 7.51M | 7.75M |
| Net Property, Plant & Equipment | 150.00K | 150.00K | 187.00K | 187.00K | 245.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.60M | 16.60M | 11.28M | 11.28M | 10.96M |
|
|
|||||
| Total Accounts Payable | 7.18M | 7.18M | 5.58M | 5.58M | 7.48M |
| Total Accrued Expenses | -- | -- | 1.65M | 1.65M | 1.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 107.00K | 107.00K | 106.00K | 106.00K | 142.00K |
| Total Finance Division Other Current Liabilities | 113.00K | 113.00K | 12.00K | 12.00K | 8.00K |
| Total Other Current Liabilities | 113.00K | 113.00K | 12.00K | 12.00K | 8.00K |
| Total Current Liabilities | 7.40M | 7.40M | 7.35M | 7.35M | 9.07M |
|
|
|||||
| Total Current Liabilities | 7.40M | 7.40M | 7.35M | 7.35M | 9.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | 37.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.40M | 7.40M | 7.35M | 7.35M | 9.11M |
|
|
|||||
| Common Stock & APIC | 31.91M | 31.91M | 23.22M | 23.22M | 17.02M |
| Retained Earnings | -150.46M | -150.46M | -144.83M | -144.83M | -138.27M |
| Treasury Stock & Other | 127.76M | 127.76M | 125.55M | 125.55M | 123.11M |
| Total Common Equity | 9.20M | 9.20M | 3.94M | 3.94M | 1.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.20M | 9.20M | 3.94M | 3.94M | 1.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.20M | 9.20M | 3.94M | 3.94M | 1.86M |
|
|
|||||